BG Medicine, Inc.
OTC: BGMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Stephen Hall
- Employees
- 5
- Headquarters
- Waltham, United States
- IPO year
- 2011
- Market cap
- $1.1K
- Website
- https://www.bg-medicine.com
Loading BGMD…
Loading profile data…Frequently asked questions about BGMD
What does BG Medicine, Inc. (BGMD) do?
BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio includes the BGM Galectin-3 Test, an in vitro diagnostic solution that quantifies galectin-3 levels in blood s...
Where does BGMD trade?
BG Medicine, Inc. (BGMD) trades on the Other OTC.
What sector is BGMD in?
BG Medicine, Inc. (BGMD) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of BG Medicine, Inc.?
Stephen Hall is the chief executive officer of BG Medicine, Inc. (BGMD).
Where is BG Medicine, Inc. headquartered?
BG Medicine, Inc. is headquartered in United States.
Does BGMD pay a dividend?
BG Medicine, Inc. (BGMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BGMD go public?
BG Medicine, Inc. (BGMD) completed its initial public offering in 2011.